Sargent Bickham Lagudis LLC Caribou Biosciences, Inc. Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 162 shares of CRBU stock, worth $343. This represents 0.0% of its overall portfolio holdings.
Number of Shares
162
Previous 162
-0.0%
Holding current value
$343
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
145Shares Held
53.7MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$14.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$9.63 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$8.82 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$8.66 Million0.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.62MShares$5.56 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $129M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...